BeStock  
Markets › Compare › ASND vs INCY

ASND vs INCY

Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.

vsvs
ASND · Ascendis Pharma A/S$252.73 ▼ 1.26%
INCY · Incyte$114.63 ▼ 1.07%

One year, rebased to 100

Each line starts at 100 so growth is directly comparable

8295109122135Nov 24, '25May 22, '26Nov 20, '26
  • ASND +20.9%
  • INCY +7.9%

Head to head

MetricASNDINCY
Price$252.73$114.63
Change today▼ 1.26%▼ 1.07%
Market cap$16.63B$23.36B
Return, 3 months+0.3%-10.4%
Return, year to date+18.5%+16.1%
Return, 1 year+16.4%+12.3%
P/E (TTM)34.758.5
P/B10.14.1
P/E percentile vs own 5y100th79th
Dividend yield––
Revenue growth (YoY, latest qtr)+73.0%+14.0%
Net profit growth (YoY)+221.3%-285.0%
Gross margin91.9%92.7%
Operating margin31.3%11.7%
Net margin72.9%6.7%
Return on equity132.2%7.8%
Analyst target vs. price+26.6%+19.2%
Analyst buy share95%59%
RSI (14)4942
30-day volatility28.6%32.5%
Max drawdown, 1 year-19.7%-18.3%
Trend readLeaning bearishLeaning bearish
Analyst consensusBuyBuy

Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.

What the numbers say

  • INCY is the largest of the group by market value.
  • ASND has returned the most over the past year.
  • ASND carries the lowest trailing P/E.
  • ASND is growing revenue fastest.
  • ASND keeps the most profit per dollar of sales.
  • ASND has been the calmest stock over the last 30 days.

Go deeper

Scroll to Top